Chronic Kidney Disease and Dyslipidemias
Authors/Creators
- 1. Junior Resident-3, Department of General Medicine, Government Medical College, Aurangabad, Maharashtra, India
- 2. Associate Professor, Department of General Medicine, Government Medical College, Aurangabad, Maharashtra, India
- 3. Professor & Head, Department of General Medicine, Government Medical College, Aurangabad, Maharashtra, India
Description
Introduction: Patients of chronic kidney disease (CKD), like patients of end-stage renal disease, those who were treated with dialysis, or renal transplant recipients have an increased risk for cardiovascular disease (CVD) morbidity and mortality. Dyslipidemia is commonly seen in CKD patients, CKD is an important risk factor for cardiovascular disease (CVD) development. The purpose of this study was to study of significance of dyslipidemia in patients with chronic Kidney disease because these patients have high mortality rate due cardiovascular disease or cerebrovascular disease. Materials and Methods: This study was a cross sectional, observational study done in tertiary health care hospital and teaching institute, study period was from December 2018 to December 2020. A total 60 cases were included in this study as per inclusion criteria and exclusion criteria. Results: In the present study serum samples of 60 patients were studied to know the incidence of dyslipidemia in chronic kidney disease patients, the triglycerides, cholesterol, LDL and HDL values were measured and compared as per age and sex distribution. The p values were found to be insignificant. Conclusion: The mean values of the lipid profile showed a borderline elevation of serum triglycerides, Serum cholesterol, HDL and LDL values were within normal range. There was no statistically significant variation in the lipid profile of the patients when compared with the co-morbid conditions of diabetes mellitus and hypertension.
Abstract (English)
Introduction: Patients of chronic kidney disease (CKD), like patients of end-stage renal disease, those who were treated with dialysis, or renal transplant recipients have an increased risk for cardiovascular disease (CVD) morbidity and mortality. Dyslipidemia is commonly seen in CKD patients, CKD is an important risk factor for cardiovascular disease (CVD) development. The purpose of this study was to study of significance of dyslipidemia in patients with chronic Kidney disease because these patients have high mortality rate due cardiovascular disease or cerebrovascular disease. Materials and Methods: This study was a cross sectional, observational study done in tertiary health care hospital and teaching institute, study period was from December 2018 to December 2020. A total 60 cases were included in this study as per inclusion criteria and exclusion criteria. Results: In the present study serum samples of 60 patients were studied to know the incidence of dyslipidemia in chronic kidney disease patients, the triglycerides, cholesterol, LDL and HDL values were measured and compared as per age and sex distribution. The p values were found to be insignificant. Conclusion: The mean values of the lipid profile showed a borderline elevation of serum triglycerides, Serum cholesterol, HDL and LDL values were within normal range. There was no statistically significant variation in the lipid profile of the patients when compared with the co-morbid conditions of diabetes mellitus and hypertension.
Files
IJPCR,Vol14,Issue12,Article85.pdf
Files
(273.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7bc3f1b638134a35157bbefafa5dc147
|
273.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-12-12
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue12,Article85.pdf
- Development Status
- Active
References
- 1. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 2089-2100. 2. Ma King W, Green EL, Raij L. Cardiovascular risk factors in chronic Renal failure and hemodialysis populations. American Journal of Kidney diseases 1992; 19(6): 505-15. 3. Grundy SM. Cholesterol and coronary heart disease: A new era. JAMA 1986; 256: 2849-58. 4. Attman PO., Alauporic P. Lipid abnormalities in chronic renal Insufficiency. Kidney Int 1991; 39 (suppl 31): 16-23. 5. Ivana Mikolasevic et.al.' Dyslipidemia in patients with chronic kidney Disease: etiology and management', International Journal of Nephrology and Renovascular Disease Dovepress- open access to scientific and medical research, 2017;10: 35-45. 6. Dr. Jose Kunnel Paul, Dr. Sheela Kurian V,' Study of lipid profile in chronic kidney disease patients on nondiabetic etiology and its relation to serum calcium', Journal of Medical Science and Clinical Research, September 2017; 05(09):28284 – 28290.7. Vaziri ND. Molecular mechanisms of lipid disorders in nephritic Syndrome, Kidney International 2003; 63: 1964-76. 8. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).